Long Term Outcomes in Pancreas Cancer Patients

Overview

About this study

The purpose of this study is to access long-term quality of life, complications, and implications of treatments on patients who are long-term survivors of pancreas cancer and were treated at Mayo Clinic.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patients, ≥ 18 years old.
Treated at Mayo Clinic from 2011 to 2019 with pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC).
Alive more than 3 years from the procedure.

Exclusion Criteria:

Children < 18 years of age.
Patients who have undergone pancreatoduodenectomy (PD) for other pathology.

Eligibility last updated 4/26/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Cornelius Thiels, D.O., M.B.A.	Closed for enrollment	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Cornelius Thiels, D.O., M.B.A.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Clinical Trials